Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Forty Seven Inc
FTSV

Buy FTSV Stock

FTSV
See FTSV stock price and Buy/Sell Forty Seven Inc with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
FTSV

Forty Seven Inc (FTSV)

About Forty Seven Inc (FTSV)

Forty Seven, Inc. is a clinical-stage immuno-oncology company that is developing therapies targeting cancer immune evasion pathways based on technology licensed from Stanford University. Forty Seven's lead program, 5F9, is a monoclonal antibody against the CD47 receptor, a ''don't eat me'' signal that cancer cells commandeer to avoid being ingested by macrophages. This antibody is currently being ...Read more
Market Cap
$4.6B
1 Year High
$95.52
Volume
1 Year Low
$5.53
Price to Earnings Ratio
Open
Dividend Rate
High
Dividend Yield
Low

Community

People who own or watch FTSV stock

FTSV Stock News

FTSV stock rating

What analysts recommend for FTSV stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
3

FTSV price target

What analysts think FTSV will be worth
Low $0
High $95.52
Current $0
Target $95.50

Events

List of events that could affect FTSV stock.
20Mar

Earnings data Q4 2019

11May

Earnings data Q1 2020

FTSV earnings

The value each share was expected to gain vs. the value that each share actually gained
0
-0.35
-0.71
-1.06
Q4 2020
Q1 2021
Q2 2021
Q3 2021
Q4 2021

Expected EPS
Q4 2021
-$1.06
Actual EPS
Q4 2021

Buy FTSV Stock

FTSV
See FTSV stock price and Buy/Sell Forty Seven Inc with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch FTSV stock
  • denildo avatar
  • LoRob81 avatar
  • shger avatar
  • kkhalasi avatar
  • PFLEGACY avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.